Solicitation for written comments on draft National Action Plan for Adverse Drug Event Prevention.

Provide Feedback |

Submit a Case

Government Resource

Solicitation for written comments on draft National Action Plan for Adverse Drug Event Prevention.

September 18, 2013

Federal Register. Washington, DC: Office of Disease Prevention and Health Promotion. September 4, 2013;78:54469-54470.

This notice calls for comments on a proposed government plan to research and promote adverse drug event reduction. The process for submitting public comments is now closed.

Information

Related Resources

National Healthcare Quality and Disparities Report Chartbook on Patient Safety.

March 22, 2023

AHRQ Safety Program for Telemedicine.

January 19, 2023 - January 19, 2023

Diagnostic Errors in the Emergency Department: a Systematic Review.

December 21, 2022

Request for Information: Creating a National Healthcare System Action Alliance to Advance Patient Safety.

December 21, 2022

National Healthcare Quality and Disparities Reports.

November 7, 2022

The National Healthcare System Action Alliance to Advance Patient Safety.

November 14, 2022 - November 14, 2022

Opportunities to Improve Patient Safety, Advancing U.S. Innovation, and Innovation Hubs.

October 5, 2022

Who killed patient safety?

July 20, 2022

Agency Information Collection Activities: Proposed Collection; Comment Request, "Hospital Survey on Patient Safety Culture Comparative Database.''

June 22, 2022

Safety Considerations for Container Labels and Carton Labeling Design to Minimize Medication Errors: Guidance for Industry.

May 25, 2022

COVID-19 Focused Inspection Initiative in Healthcare.

March 23, 2022

Proposed 2022 CDC clinical practice guideline for prescribing opioids. A notice by the Centers for Disease Control and Prevention.

February 23, 2022

Strategies to Improve Patient Safety: Final Report to Congress Required by the Patient Safety and Quality Improvement Act of 2005.

December 15, 2021

Input for the TeamSTEPPS Curriculum Updates.

December 15, 2021

An Investigation into the Death of Baby J at University Hospitals Bristol and Weston NHS Foundation Trust.

November 3, 2021

Public comment period extended for strategies to improve patient safety: Draft Report to Congress for Public Comment and Review by the National Academy of Medicine.

March 31, 2021

Best Practices in Developing Proprietary Names for Human Nonprescription Drug Products.

January 13, 2021

Telediagnosis for Acute Care: Implications for the Quality and Safety of Diagnosis.

August 19, 2020

FDA recommends health care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder.

August 5, 2020

Culture as a Cure: Assessments of Patient Safety Culture in OECD Countries.

July 15, 2020

Health Services Research Priorities for Improving Diagnostic Safety and Quality. Special Emphasis Notice (SEN).

January 15, 2020

Independent Review of Gross Negligence Manslaughter and Culpable Homicide.

July 17, 2019

Addressing Problematic Opioid Use in OECD Countries.

June 5, 2019

Communication and Resolution After an Adverse Health Care Incident.

May 22, 2019

NHS Improvement.

May 18, 2019

Interview

In Conversation With… … Jennifer Schulz Moore, LLB, MA, PhD

April 1, 2019

Use of a public health law framework to improve medication safety by anesthesia providers.

March 20, 2019

FDA Safety Communication: recommendations to reduce surgical fires and related patient injury.

June 20, 2018

Request for comments on the proposed measures and 2020 targets for the National Action Plan for Adverse Drug Event Prevention: inpatient and outpatient measures for reduction of adverse drug events from anticoagulants, diabetes agents, and opioid analgesics.

November 2, 2016

Developing and Testing the Health Care Safety Hotline: A Prototype Consumer Reporting System for Patient Safety Events. Final Report.

May 25, 2016

See More About

Health Care Providers

Health Care Executives and Administrators

Safety Scientists

Policy Makers

Medication Errors/Preventable Adverse Drug Events

To sign up for updates or to access your subscriber preferences, please enter your email address below.

5600 Fishers Lane
Rockville, MD 20857
Telephone: (301) 427-1364

Solicitation for written comments on draft National Action Plan for Adverse Drug Event Prevention.

Connect With Us

Sign up for Email Updates

Agency for Healthcare Research and Quality

Solicitation for written comments on draft National Action Plan for Adverse Drug Event Prevention.

Connect With Us

Sign up for Email Updates

Agency for Healthcare Research and Quality

PSNet Log in

Submit Your Case

Continue as a Guest

Continue Logged In

Submit Your Case

Continue as a Guest

Already have a PSNet

Account?

New Users